Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2001;98:1104-1108
© 2001 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stringer, E. M.
Right arrow Articles by Goepfert, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stringer, E. M.
Right arrow Articles by Goepfert, A. R.

ORIGINAL RESEARCH

Evaluation of a New Testing Policy for Human Immunodeficiency Virus to Improve Screening Rates

Elizabeth M. Stringer, MD, Jeffrey S. A. Stringer, MD, Suzanne P. Cliver, Robert L. Goldenberg, MD and Alice R. Goepfert, MD

From the Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.

Address reprint requests to: Alice R. Goepfert, MD, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 619 19th Street, OHB 450, Birmingham, AL 35249-7333; E-mail: aliceg{at}uab.edu.

OBJECTIVE: To assess the effect of a change in human immunodeficiency virus (HIV) testing policy on HIV testing rates in an urban maternity clinic population.

METHODS: Since 1995, our institution has provided pretest counseling and voluntary HIV testing to all pregnant women. After the 1999 Institute of Medicine recommendation of HIV testing with patient notification as a routine component of prenatal care, we conducted a prospective study to determine whether this policy would increase our HIV screening rates. The intervention incorporated HIV testing into the routine battery of tests drawn at antenatal care. Not to be tested required active refusal. The intervention group was comprised of all women receiving an initial antenatal visit in one of our eight maternity clinics between August 1, 1999, and July 30, 2000. The control group was comprised of all women presenting for prenatal care in the same clinics during the year before the intervention.

RESULTS: The 3415 women in the intervention group and 3778 controls were similar with respect to most demographic and risk factors. After the intervention, HIV testing increased from 75% to 88% (P < .001). Among all women in both years of the study, women who were in the intervention group, less than 20 years of age, or who had a history of substance abuse, were more likely not to refuse testing.

CONCLUSION: After implementation of a policy of routine HIV testing with active patient refusal, HIV testing rates increased among pregnant women in our large, urban obstetric clinic population.




This article has been cited by other articles:


Home page
PediatricsHome page
Committee on Pediatric AIDS
HIV Testing and Prophylaxis to Prevent Mother-to-Child Transmission in the United States
Pediatrics, November 1, 2008; 122(5): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
A. D. Gray, R. Carlson, M. A. Morgan, D. Hawks, and J. Schulkin
Obstetrician Gynecologists' Knowledge and Practice Regarding Human Immunodeficiency Virus Screening
Obstet. Gynecol., November 1, 2007; 110(5): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. H. Yudin, C. Moravac, and R. R. Shah
Influence of an "Opt-Out" Test Strategy and Patient Factors on Human Immunodeficiency Virus Screening in Pregnancy
Obstet. Gynecol., July 1, 2007; 110(1): 81 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
U. Schuklenk and A. Kleinsmidt
Rethinking Mandatory HIV Testing During Pregnancy in Areas With High HIV Prevalence Rates: Ethical and Policy Issues
Am J Public Health, July 1, 2007; 97(7): 1179 - 1183.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. Chou, A. K. Smits, L. H. Huffman, R. Fu, and P. T. Korthuis
Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, July 5, 2005; 143(1): 38 - 54.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
L. M. Mofenson
Successes and Challenges in the Perinatal HIV-1 Epidemic in the United States as Illustrated by the HIV-1 Serosurvey of Childbearing Women
Arch Pediatr Adolesc Med, May 1, 2004; 158(5): 422 - 425.
[Full Text] [PDF]


Home page
CMAJHome page
G. C. Jayaraman, J. K. Preiksaitis, and B. Larke
Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates
Can. Med. Assoc. J., March 18, 2003; 168(6): 679 - 682.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. Walmsley
Opt in or opt out: What is optimal for prenatal screening for HIV infection?
Can. Med. Assoc. J., March 18, 2003; 168(6): 707 - 708.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Routine HIV Testing of Prenatal Patients Improves Screening Rates
Journal Watch (General), December 25, 2001; 2001(1225): 2 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Obstetricians and Gynecologists.